SOUTH SAN FRANCISCO, Calif.,
Oct. 27, 2015 /PRNewswire/
-- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today
announced that it will report its third quarter 2015 financial
results after market close on Tuesday,
November 3, 2015. Rigel senior management will follow
the announcement with a live conference call and webcast at
5:00pm Eastern Time (2:00pm Pacific Time) to discuss the financial
results.
Participants can access the live conference call by dialing
855-892-1489 (domestic) or 720-634-2939 (international) and using
the Conference ID number 65636822. The conference call will
also be webcast live and can be accessed from Rigel's website at
www.rigel.com. The webcast will be archived and
available for replay for 30 days after the call via the Rigel
website.
About Rigel (www.rigel.com)
Rigel Pharmaceuticals, Inc. is a clinical-stage biotechnology
company focused on the discovery and development of novel,
small-molecule drugs for the treatment of immune diseases and
cancers. Rigel's pioneering research focuses on signaling pathways
that are critical to disease mechanisms. Rigel currently has the
following product candidates in development: fostamatinib, an oral
spleen tyrosine kinase (SYK) inhibitor, which is in Phase 3
clinical trials for ITP and a Phase 2 clinical trial for IgA
nephropathy (IgAN); R348, a topical ophthalmic JAK/SYK inhibitor,
in a Phase 2 clinical trial for dry eye in ocular graft-versus-host
disease (GvHD); two oncology product candidates in Phase 1
development with partners BerGenBio AG and Daiichi
Sankyo; and three preclinical programs with partners
AstraZeneca for R256 in asthma, Bristol-Myers Squibb for TGF beta
inhibitors in immuno-oncology and Aclaris Therapeutics for certain
JAK inhibitors in dermatology.
Contact: Raul Rodriguez
Phone: 650.624.1302
Email: invrel@rigel.com
Media Contact: Susan C. Rogers,
Rivily, Inc.
Phone: 650.430.3777
Email: susan@rivily.com
Logo - http://photos.prnewswire.com/prnh/20030226/RIGLLOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/rigel-announces-conference-call-and-webcast-to-report-third-quarter-2015-financial-results-300166623.html
SOURCE Rigel Pharmaceuticals, Inc.